Home / Articles / Mono- and sesquiterpenes as a starting platform for the development of antiviral drugs

Mono- and sesquiterpenes as a starting platform for the development of antiviral drugs

Olga Ivanovna Yarovaya 1
Olga Ivanovna Yarovaya
, 
Nariman Faridovich Salakhutdinov 1
Nariman Faridovich Salakhutdinov
1 N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistryof the Siberian Branch of Russian Academy of Sciences
10.1070/RCR4969
Published 30 November 2020
Review , RCR4969, Volume 90, Issue 4, 488-510
67
Share
Cite this
GOST
 | 
Cite this
GOST
Copy cite
Yarovaya O. I., Salakhutdinov N. F. Mono- and sesquiterpenes as a starting platform for the development of antiviral drugs // Russian Chemical Reviews. 2020. Vol. 90. No. 4. pp. 488-510.
GOST all authors (up to 50)
Copy cite
Yarovaya O. I., Salakhutdinov N. F. Mono- and sesquiterpenes as a starting platform for the development of antiviral drugs // Russian Chemical Reviews. 2020. Vol. 90. No. 4. pp. 488-510.
RIS
 | 
Cite this
RIS
Copy cite
TY - JOUR
DO - 10.1070/RCR4969
UR - https://rcr.colab.ws/publications/10.1070/RCR4969
TI - Mono- and sesquiterpenes as a starting platform for the development of antiviral drugs
T2 - Russian Chemical Reviews
AU - Yarovaya, Olga Ivanovna
AU - Salakhutdinov, Nariman Faridovich
PY - 2020
DA - 2020/11/30
PB - ANO Editorial Board of the journal Uspekhi Khimii
SP - 488-510
IS - 4
VL - 90
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors)
Copy cite
@article{2020_Yarovaya,
author = {Olga Ivanovna Yarovaya and Nariman Faridovich Salakhutdinov},
title = {Mono- and sesquiterpenes as a starting platform for the development of antiviral drugs},
journal = {Russian Chemical Reviews},
year = {2020},
volume = {90},
publisher = {ANO Editorial Board of the journal Uspekhi Khimii},
month = {Nov},
url = {https://rcr.colab.ws/publications/10.1070/RCR4969},
number = {4},
pages = {488--510},
doi = {10.1070/RCR4969}
}
MLA
Cite this
MLA
Copy cite
Yarovaya, Olga Ivanovna, and Nariman Faridovich Salakhutdinov. “Mono- and sesquiterpenes as a starting platform for the development of antiviral drugs.” Russian Chemical Reviews, vol. 90, no. 4, Nov. 2020, pp. 488-510. https://rcr.colab.ws/publications/10.1070/RCR4969.
Views / Visits / Downloads
26 / 25 / 3

Keywords

Antiviral mechanism
monoterpene
sesquiterpene
Viruses

Abstract

The revies focuses on low-molecular-weight plant metabolites (mono- and sesquiterpenes) exhibiting antiviral activity. Data on antiviral action of both essential oils and plant extracts and their components are provided. Structures of biologically active natural mono- and sesquiterpenoids as well as their derivatives showing a pronounced antiviral activity are presented. A special attention is given to the description of targets for antiviral therapy. The mechanisms of action of antiviral agents are considered.

The bibliography includes 163 references.

Funders

Russian Foundation for Basic Research
19-13-50120

References

1.
rcr_90_4_488bib1
Dimmock
2015
2.
rcr_90_4_488bib2
Acheson
2011
3.
Approved Antiviral Drugs over the Past 50 Years
De Clercq E., Li G.
Clinical Microbiology Reviews , 2016
4.
Molecular basis of COVID-19 pathogenesis
Novikov F.N., Stroylov V.S., Svitanko I.V., Nebolsin V.E.
Russian Chemical Reviews , 2020
6.
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015
Hurt A.C., Besselaar T.G., Daniels R.S., Ermetal B., Fry A., Gubareva L., Huang W., Lackenby A., Lee R.T., Lo J., Maurer-Stroh S., Nguyen H.T., Pereyaslov D., Rebelo-de-Andrade H., Siqueira M.M., et. al.
Antiviral Research , 2016
7.
Influenza neuraminidase: A druggable target for natural products
Grienke U., Schmidtke M., von Grafenstein S., Kirchmair J., Liedl K.R., Rollinger J.M.
Natural Product Reports , 2012
8.
Wu X., Wu X., Sun Q., Zhang C., Yang S., Li L., Jia Z.
Theranostics , 2017
9.
rcr_90_4_488bib9
Kró
Acta Biochim. Polonica , 2014
10.
Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
Boldescu V., Behnam M.A., Vasilakis N., Klein C.D.
Nature Reviews Drug Discovery , 2017
11.
Potential Antivirals: Natural Products Targeting Replication Enzymes of Dengue and Chikungunya Viruses
Oliveira A.F., Teixeira R.R., Oliveira A.S., Souza A.P., Silva M.L., Paula S.O.
Molecules , 2017
12.
A review of non-nucleoside anti-hepatitis B virus agents.
Zhang F., Wang G.
European Journal of Medicinal Chemistry , 2014
14.
Human herpes simplex virus: Life cycle and development of inhibitors
Kukhanova M.K., Korovina A.N., Kochetkov S.N.
Biochemistry (Moscow) , 2014
15.
Novel agents and strategies to treat herpes simplex virus infections
Kleymann G.
Expert Opinion on Investigational Drugs , 2005
16.
Small molecules with antiviral activity against the Ebola virus
Litterman N., Lipinski C., Ekins S.
F1000Research , 2015
17.
Small molecule inhibitors of ebola virus infection.
Picazo E., Giordanetto F.
Drug Discovery Today , 2015
18.
The medicinal chemistry of Chikungunya virus
da Silva-Júnior E.F., Leoncini G.O., Rodrigues É.E., Aquino T.M., Araújo-Júnior J.X.
Bioorganic and Medicinal Chemistry , 2017
22.
Recent advances in anti-HIV natural products
Singh I.P., Bodiwala H.S.
Natural Product Reports , 2010
23.
Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview
Kurapati K.R., Atluri V.S., Samikkannu T., Garcia G., Nair M.P.
Frontiers in Microbiology , 2016
24.
Extracts and molecules from medicinal plants against herpes simplex viruses.
Khan M.T., Ather A., Thompson K.D., Gambari R.
Antiviral Research , 2005
25.
Bioactive natural products with anti‐herpes simplex virus properties
Hassan S.T., Masarčíková R., Berchová K.
Journal of Pharmacy and Pharmacology , 2015
26.
Development of anti-viral agents using molecular modeling and virtual screening techniques.
Kirchmair J., Distinto S., Roman Liedl K., Markt P., Maria Rollinger J., Schuster D., Maria Spitzer G., Wolber G.
Infectious Disorders - Drug Targets , 2011
27.
Identification of small molecule inhibitors for influenza a virus using in silico and in vitro approaches
Makau J.N., Watanabe K., Ishikawa T., Mizuta S., Hamada T., Kobayashi N., Nishida N.
PLoS ONE , 2017
28.
rcr_90_4_488bib28
El Sayed
Nat. Prod. Antiviral Agents , 2000
29.
Natural Antiviral Compounds
Bekhit A.E., Bekhit A.A.
Studies in Natural Products Chemistry , 2014
30.
The structural modification of natural products for novel drug discovery
Yao H., Liu J., Xu S., Zhu Z., Xu J.
Expert Opinion on Drug Discovery , 2016
31.
Monoterpenes as a renewable source of biologically active compounds
Salakhutdinov N.F., Volcho K.P., Yarovaya O.I.
Pure and Applied Chemistry , 2017
32.
Natural Products as Sources of New Drugs from 1981 to 2014
Newman D.J., Cragg G.M.
Journal of Natural Products , 2016
33.
New Horizons for Old Drugs and Drug Leads
Cragg G.M., Grothaus P.G., Newman D.J.
Journal of Natural Products , 2014
34.
Novel antiviral agents: a medicinal plant perspective
Jassim S.A., Naji M.A.
Journal of Applied Microbiology , 2003
35.
Sohail M.N., Rasul F., Karim A., Kanwal U., Attitalla I.H.
Asian Journal of Animal and Veterinary Advances , 2011
36.
rcr_90_4_488bib36
Pushpa
Int. Res. J. Pharm. , 2013
37.
In vitro antiviral activity of plant extracts from Asteraceae medicinal plants
Visintini Jaime M.F., Redko F., Muschietti L.V., Campos R.H., Martino V.S., Cavallaro L.V.
Virology Journal , 2013
38.
Development of New Antiviral Agents from Natural Products
Kurokawa M., Shimizu T., Watanabe W., Shiraki K.
The Open Antimicrobial Agents Journal , 2010
39.
rcr_90_4_488bib39
Vijayan
Indian J. Med. Res. , 2004
41.
Antiviral activity of Myracrodruon urundeuva against rotavirus
Cecílio A.B., Oliveira P.D., Caldas S., Campana P.R., Francisco F.L., Duarte M.G., Mendonça L.D., de Almeida V.L.
Revista Brasileira de Farmacognosia , 2016
42.
Antiviral activity of hydroalcoholic extract from Eupatorium perfoliatum L. against the attachment of influenza A virus.
Derksen A., Kühn J., Hafezi W., Sendker J., Ehrhardt C., Ludwig S., Hensel A.
Journal of Ethnopharmacology , 2016
44.
Melissa officinalis L. - A review of its traditional uses, phytochemistry and pharmacology.
Shakeri A., Sahebkar A., Javadi B.
Journal of Ethnopharmacology , 2016
45.
Jalali P., Moattari A., Mohammadi A., Ghazanfari N., Pourghanbari G.
Asian Pacific Journal of Tropical Disease , 2016
46.
Phytochemical analysis and in vitro evaluation of the biological activity against herpes simplex virus type 1 (HSV-1) of Cedrus libani A. Rich.
Loizzo M.R., Saab A., Tundis R., Statti G.A., Lampronti I., Menichini F., Gambari R., Cinatl J., Doerr H.W.
Phytomedicine , 2008
47.
Terpenes: substances useful in human healthcare
Paduch R., Kandefer-Szerszeń M., Trytek M., Fiedurek J.
Archivum Immunologiae et Therapiae Experimentalis , 2007
48.
rcr_90_4_488bib48
Orhan
Turk. J. Biol. , 2012
49.
Activity of Melaleuca alternifolia (tea tree) oil on Influenza virus A/PR/8: study on the mechanism of action.
Garozzo A., Timpanaro R., Stivala A., Bisignano G., Castro A.
Antiviral Research , 2011
50.
The in vitro and in vivo antiviral properties of combined monoterpene alcohols against West Nile virus infection.
Pliego Zamora A., Edmonds J.H., Reynolds M.J., Khromykh A.A., Ralph S.J.
Virology , 2016
54.
1, 8-Cineol Protect Against Influenza-Virus-Induced Pneumonia in Mice
Li Y., Lai Y., Wang Y., Liu N., Zhang F., Xu P.
Inflammation , 2016
55.
Antiviral properties of isoborneol, a potent inhibitor of herpes simplex virus type 1.
Armaka M., Papanikolaou E., Sivropoulou A., Arsenakis M.
Antiviral Research , 1999
56.
In vitro inhibition of herpes simplex virus type 1 replication by Mentha suaveolens essential oil and its main component piperitenone oxide.
Civitelli L., Panella S., Marcocci M.E., De Petris A., Garzoli S., Pepi F., Vavala E., Ragno R., Nencioni L., Palamara A.T., Angiolella L.
Phytomedicine , 2014
57.
Lamiridosins, Hepatitis C Virus Entry Inhibitors from Lamium album
Zhang H., Rothwangl K., Mesecar A.D., Sabahi A., Rong L., Fong H.H.
Journal of Natural Products , 2009
58.
Privileged scaffolds for library design and drug discovery
Welsch M.E., Snyder S.A., Stockwell B.R.
Current Opinion in Chemical Biology , 2010
60.
Functionalized Benzimidazole Scaffolds: Privileged Heterocycle for Drug Design in Therapeutic Medicine
Ajani O.O., Aderohunmu D.V., Ikpo C.O., Adedapo A.E., Olanrewaju I.O.
Archiv der Pharmazie , 2016
61.
rcr_90_4_488bib61
Jones
2017
62.
Chalcone: A Privileged Structure in Medicinal Chemistry.
Zhuang C., Zhang W., Sheng C., Zhang W., Xing C., Miao Z.
Chemical Reviews , 2017
63.
Adamantane – A Lead Structure for Drugs in Clinical Practice
Spilovska K., Zemek F., Korabecny J., Nepovimova E., Soukup O., Windisch M., Kuca K.
Current Medicinal Chemistry , 2016
66.
Synthesis of New Compounds Combining Adamantanamine and Monoterpene Fragments and their Antiviral Activity Against Influenza Virus A(H1N1)pdm09
Teplov G.V., Suslov E.V., Zarubaev V.V., Shtro A.A., Karpinskaya L.A., Rogachev A.D., Korchagina D.V., Volcho K.P., Salakhutdinov N.F., Kiselev O.I.
Letters in Drug Design and Discovery , 2013
67.
Anti-influenza activity of diazaadamantanes combined with monoterpene moieties
Suslov E., Zarubaev V.V., Slita A.V., Ponomarev K., Korchagina D., Ayine-Tora D.M., Reynisson J., Volcho K., Salakhutdinov N.
Bioorganic and Medicinal Chemistry Letters , 2017
68.
rcr_90_4_488bib68
69.
Antiviral Activity of 3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol and its Derivatives Against Influenza A(H1N1)2009 Virus
V. Ardashov O., V. Zarubaev V., A. Shtro A., V. Korchagina D., P. Volcho K., F. Salakhutdinov N., I. Kiselev O.
Letters in Drug Design and Discovery , 2011
70.
Anti-influenza activity of monoterpene-derived substituted hexahydro-2H-chromenes.
Patrusheva O.S., Zarubaev V.V., Shtro A.A., Orshanskaya Y.R., Boldyrev S.A., Ilyina I.V., Kurbakova S.Y., Korchagina D.V., Volcho K.P., Salakhutdinov N.F.
Bioorganic and Medicinal Chemistry , 2016
71.
Influenza Antiviral Activity of Br-Containing [2R,4R(S),4aR,7R,8aR]-4,7-Dimethyl-2-(Thiophen-2-YL)Octahydro-2H-Chromen-4-Ols Prepared from (–)-Isopulegol
Nazimova E.V., Shtro A.A., Anikin V.B., Patrusheva O.S., Il′ina I.V., Korchagina D.V., Zarubaev V.V., Volcho K.P., Salakhutdinov N.F.
Chemistry of Natural Compounds , 2017
72.
Highly potent activity of isopulegol-derived substituted octahydro-2H-chromen-4-ols against influenza A and B viruses.
Ilyina I.V., Zarubaev V.V., Lavrentieva I.N., Shtro A.A., Esaulkova I.L., Korchagina D.V., Borisevich S.S., Volcho K.P., Salakhutdinov N.F.
Bioorganic and Medicinal Chemistry Letters , 2018
73.
Synthesis of oxygen-containing heterocyclic compounds based on monoterpenoids
Patrusheva O.S., Volcho K.P., Salakhutdinov N.F.
Russian Chemical Reviews , 2018
74.
Therapeutic potential of coumarins as antiviral agents
Hassan M.Z., Osman H., Ali M.A., Ahsan M.J.
European Journal of Medicinal Chemistry , 2016
75.
Recent progress in the development of coumarin derivatives as potent anti‐HIV agents
Yu D., Suzuki M., Xie L., Morris-Natschke S.L., Lee K.
Medicinal Research Reviews , 2003
76.
Anti-AIDS Agents. 15. Synthesis and Anti-HIV Activity of Dihydroseselins and Related Analogs
Huang L., Kashiwada Y., Cosentino L.M., Fan S., Chen C., McPhail A.T., Fujioka T., Mihashi K., Lee K.
Journal of Medicinal Chemistry , 1994
80.
Anti-AIDS agents 87. New bio-isosteric dicamphanoyl-dihydropyranochromone (DCP) and dicamphanoyl-khellactone (DCK) analogues with potent anti-HIV activity.
Liu H., Xu S., Cheng M., Chen Y., Xia P., Qian K., Xia Y., Yang Z., Chen C., Morris-Natschke S.L., Lee K.
Bioorganic and Medicinal Chemistry Letters , 2011
81.
Anti-AIDS Agents. 52. Synthesis and Anti-HIV Activity of Hydroxymethyl (3‘R,4‘R)-3‘,4‘-Di-O-(S)-camphanoyl-(+)-cis-khellactone Derivatives
Xie L., Yu D., Wild C., Allaway G., Turpin J., Smith P.C., Lee K.
Journal of Medicinal Chemistry , 2003
82.
Molecular modeling, design, synthesis, and biological evaluation of novel 3',4'-dicamphanoyl-(+)-cis-khellactone (DCK) analogs as potent anti-HIV agents.
Xie L., Zhao C., Zhou T., Chen H., Fan B., Chen X., Ma J., Li J., Bao Z., Lo Z., Yu D., Lee K.
Bioorganic and Medicinal Chemistry , 2005
83.
Anti-influenza activity of monoterpene-containing substituted coumarins.
Khomenko T.M., Zarubaev V.V., Orshanskaya I.R., Kadyrova R.A., Sannikova V.A., Korchagina D.V., Volcho K.P., Salakhutdinov N.F.
Bioorganic and Medicinal Chemistry Letters , 2017
84.
Identification of Hits as Matrix-2 Protein Inhibitors through the Focused Screening of a Small Primary Amine Library
Hu W., Zeng S., Li C., Jie Y., Li Z., Chen L.
Journal of Medicinal Chemistry , 2010
85.
Discovery of highly potent agents against influenza A virus.
Zhao X., Li C., Zeng S., Hu W.
European Journal of Medicinal Chemistry , 2011
86.
Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors.
Zhao X., Jie Y., Rosenberg M.R., Wan J., Zeng S., Cui W., Xiao Y., Li Z., Tu Z., Casarotto M.G., Hu W.
Antiviral Research , 2012
87.
Imidazole-based pinanamine derivatives: Discovery of dual inhibitors of the wild-type and drug-resistant mutant of the influenza A virus.
Dong J., Chen S., Li R., Cui W., Jiang H., Ling Y., Yang Z., Hu W.
European Journal of Medicinal Chemistry , 2016
88.
Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses
Zhao X., Li R., Zhou Y., Xiao M., Ma C., Yang Z., Zeng S., Du Q., Yang C., Jiang H., Hu Y., Wang K., Mok C.K., Sun P., Dong J., et. al.
Journal of Medicinal Chemistry , 2018
89.
Synthesis of substituted 1-norbornylamines with antiviral activity.
Garcia Martinez A., Teso Vilar E., Garcia Fraile A., de la Cerero S., Rodriguez Herrero M.E., Martinez Ruiz P., Subramanian L.R., Garcia Gancedo A.
Journal of Medicinal Chemistry , 1995
90.
Identification of camphor derivatives as novel M2 ion channel inhibitors of influenza A virus
Zhao X., Zhang Z., Cui W., Chen S., Zhou Y., Dong J., Jie Y., Wan J., Xu Y., Hu W.
MedChemComm , 2015
91.
Discovery of a new class of antiviral compounds: Camphor imine derivatives
Sokolova A.S., Yarovaya O.I., Shernyukov A.V., Gatilov Y.V., Razumova Y.V., Zarubaev V.V., Tretiak T.S., Pokrovsky A.G., Kiselev O.I., Salakhutdinov N.F.
European Journal of Medicinal Chemistry , 2015
92.
Broad range of inhibiting action of novel camphor-based compound with anti-hemagglutinin activity against influenza viruses in vitro and in vivo.
Zarubaev V.V., Garshinina A.V., Tretiak T.S., Fedorova V.A., Shtro A.A., Sokolova A.S., Yarovaya O.I., Salakhutdinov N.F.
Antiviral Research , 2015
93.
Aliphatic and alicyclic camphor imines as effective inhibitors of influenza virus H1N1
Sokolova A.S., Yarovaya О.I., Baev D.S., Shernyukov А.V., Shtro A.A., Zarubaev V.V., Salakhutdinov N.F.
European Journal of Medicinal Chemistry , 2017
94.
Synthesis of camphecene derivatives using click chemistry methodology and study of their antiviral activity.
Artyushin O.I., Sharova E.V., Vinogradova N.M., Genkina G.K., Moiseeva A.A., Klemenkova Z.S., Orshanskaya I.R., Shtro A.A., Kadyrova R.A., Zarubaev V.V., Yarovaya O.I., Salakhutdinov N.F., Brel V.K.
Bioorganic and Medicinal Chemistry Letters , 2017
95.
Synthesis of Camphecene and Cytisine Conjugates Using Click Chemistry Methodology and Study of Their Antiviral Activity
Artyushin O.I., Moiseeva A.A., Zarubaev V.V., Slita A.V., Galochkina A.V., Muryleva A.A., Borisevich S.S., Yarovaya O.I., Salakhutdinov N.F., Brel V.K.
Chemistry and Biodiversity , 2019
96.
Synthesis and structure-activity relationships of novel camphecene analogues as anti-influenza agents.
Yarovaya O.I., Sokolova A.S., Mainagashev I.Y., Volobueva A.S., Lantseva K., Borisevich S.S., Shtro A.A., Zarubaev V.V., Salakhutdinov N.F.
Bioorganic and Medicinal Chemistry Letters , 2019
97.
Camphor-based symmetric diimines as inhibitors of influenza virus reproduction
Sokolova A.S., Yarovaya О.I., Korchagina D.V., Zarubaev V.V., Tretiak T.S., Anfimov P.M., Kiselev O.I., Salakhutdinov N.F.
Bioorganic and Medicinal Chemistry , 2014
98.
New quaternary ammonium camphor derivatives and their antiviral activity, genotoxic effects and cytotoxicity
Sokolova A.S., Yarovaya О.I., Shernyukov А.V., Pokrovsky М.A., Pokrovsky А.G., Lavrinenko V.A., Zarubaev V.V., Tretiak T.S., Anfimov P.M., Kiselev O.I., Beklemishev A.B., Salakhutdinov N.F.
Bioorganic and Medicinal Chemistry , 2013
99.
Synthesis and antiviral activity of camphor-based 1,3-thiazolidin-4-one and thiazole derivatives as Orthopoxvirus-reproduction inhibitors
Sokolova A.S., Yarovaya O.I., Bormotov N.I., Shishkina L.N., Salakhutdinov N.F.
MedChemComm , 2018
100.
Synthesis ofd-(+)-camphor-basedN-acylhydrazones and their antiviral activity
Kovaleva K.S., Zubkov F.I., Bormotov N.I., Novikov R.A., Dorovatovskii P.V., Khrustalev V.N., Gatilov Y.V., Zarubaev V.V., Yarovaya O.I., Shishkina L.N., Salakhutdinov N.F.
MedChemComm , 2018
101.
Synthesis of (1S)-(+)-camphor-10-sulfonic acid derivatives and investigations in vitro and in silico of their antiviral activity as the inhibitors of fi lovirus infections
Sokolova A.S., Baranova D.V., Yarovaya O.I., Baev D.S., Polezhaeva O.A., Zybkina A.V., Shcherbakov D.N., Tolstikova T.G., Salakhutdinov N.F.
Russian Chemical Bulletin , 2019
102.
Synthesis and in vitro study of novel borneol derivatives as potent inhibitors of the influenza A virus
Sokolova A.S., Yarovaya O.I., Semenova M.D., Shtro A.A., Orshanskaya I.R., Zarubaev V.V., Salakhutdinov N.F.
MedChemComm , 2017
103.
N-Heterocyclic borneol derivatives as inhibitors of Marburg virus glycoprotein-mediated VSIV pseudotype entry
Kononova A.A., Sokolova A.S., Cheresiz S.V., Yarovaya O.I., Nikitina R.A., Chepurnov A.A., Pokrovsky A.G., Salakhutdinov N.F.
MedChemComm , 2017
104.
rcr_90_4_488bib104
105.
rcr_90_4_488bib105
106.
Discovery of a New Class of Inhibitors of Vaccinia Virus Based on (−)-Borneol from Abies sibirica and (+)-Camphor
Sokolova A.S., Yarovaya O.I., Bormotov N.I., Shishkina L.N., Salakhutdinov N.F.
Chemistry and Biodiversity , 2018
107.
Antiulcerogenic activity of borneol derivatives
Borisova M.S., Yarovaya O.I., Semenova M.D., Tolstikova T.G., Salakhutdinov N.F.
Russian Chemical Bulletin , 2018
108.
Synthesis and biological activity of heterocyclic borneol derivatives
Sokolova A.S., Yarovaya O.I., Shtro A.A., Borisova M.S., Morozova E.A., Tolstikova T.G., Zarubaev V.V., Salakhutdinov N.F.
Chemistry of Heterocyclic Compounds , 2017
109.
rcr_90_4_488bib109
110.
Single-stage synthesis of heterocyclic alkaloid-like compounds from (+)-camphoric acid and their antiviral activity
Chernyshov V.V., Yarovaya O.I., Fadeev D.S., Gatilov Y.V., Esaulkova Y.L., Muryleva A.S., Sinegubova K.O., Zarubaev V.V., Salakhutdinov N.F.
Molecular Diversity , 2019
111.
Synthesis of cyclic D-(+)-camphoric acid imides and study of their antiviral activity
Chernyshov V.V., Yarovaya O.I., Peshkov R.Y., Salakhutdinov N.F.
Chemistry of Heterocyclic Compounds , 2020
112.
rcr_90_4_488bib112
Astani
2011
113.
rcr_90_4_488bib113
Hu
2017
114.
Patchouli alcohol: in vitro direct anti-influenza virus sesquiterpene in Pogostemon cablin Benth.
Kiyohara H., Ichino C., Kawamura Y., Nagai T., Sato N., Yamada H.
Journal of Natural Medicines , 2011
116.
Oral administration of patchouli alcohol isolated from Pogostemonis Herba augments protection against influenza viral infection in mice.
Li Y., Peng S., Chen H., Zhang F., Xu P., Xie J., He J., Chen J., Lai X., Su Z.
International Immunopharmacology , 2012
117.
A new antiviral and antimicrobial sesquiterpene from Glyptopetalum sclerocarpum.
Sotanaphun U., Lipipun V., Suttisri R., Bavovada R.
Planta Medica , 1999
119.
In vitro anti-viral effect of β-santalol against influenza viral replication.
Paulpandi M., Kannan S., Thangam R., Kaveri K., Gunasekaran P., Rejeeth C.
Phytomedicine , 2012
120.
Sesquiterpenes and butenolides, natural anti-HIV constituents from Litsea verticillata.
Zhang H., Hung N.V., Cuong N.M., Soejarto D.D., Pezzuto J.M., Fong H.H., Tan G.T.
Planta Medica , 2005
121.
Natural anti-HIV agents. Part 3: Litseaverticillols A-H, novel sesquiterpenes from Litsea verticillata
Zhang H., Tan G.T., Hoang V.D., Hung N.V., Cuong N.M., Soejarto D.D., Pezzuto J.M., Fong H.H.
Tetrahedron , 2003
123.
Synthesis and anti-influenza activity of aminoalkyl rupestonates.
Zhao J., Aisa H.A.
Bioorganic and Medicinal Chemistry Letters , 2012
125.
Rupestonic acid derivative YZH-106 suppresses influenza virus replication by activation of heme oxygenase-1-mediated interferon response.
Ma L., Wang H., Wu P., Hu J., Yin J., Wu S., Ge M., Sun W., Zhao J., Aisa H.A., Li Y., Jiang J.
Free Radical Biology and Medicine , 2016
126.
Synthesis of Rupestonic Acid Derivatives with Antiviral Activity
Zhao J., Niu C., Li G., Aisa H.A.
Chemistry of Natural Compounds , 2017
127.
Structure-activity relationship studies of 1-(1'-hydroxyalkyl)rupestonic acid methyl esters against influenza viruses.
Li G., Zhao J., Niu C., Nie L., Dong C., Aisa H.A.
Bioorganic and Medicinal Chemistry Letters , 2017
128.
Structural modification on rupestonic acid leads to highly potent inhibitors against influenza virus
Obul M., Wang X., Zhao J., Li G., Aisa H.A., Huang G.
Molecular Diversity , 2018
129.
rcr_90_4_488bib129
Li
Bioorg. Med. Chem. Lett. , 2019
130.
rcr_90_4_488bib130
Zhao
Med. Chem. (Los Angeles) , 2016
132.
Sesquiterpenoids Lactones: Benefits to Plants and People
Chadwick M., Trewin H., Gawthrop F., Wagstaff C.
International Journal of Molecular Sciences , 2013
133.
rcr_90_4_488bib133
Chaturvedi
2011
134.
The Artemisia L. Genus: A Review of Bioactive Sesquiterpene Lactones
Abad Martínez M.J., Del Olmo L.M., Ticona L.A., Benito P.B.
Studies in Natural Products Chemistry , 2012
135.
The pharmacological activities and mechanisms of artemisinin and its derivatives: a systematic review
Dai Y., Zhou W., Meng J., Du X., Sui Y., Dai L., Wang P., Huo H., Sui F.
Medicinal Chemistry Research , 2017
136.
Advances in the Chemical Synthesis of Artemisinin
Wang Z., Yang L., Yang X., Zhang X.
Synthetic Communications , 2014
137.
Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices.
YEUNG S., PONGTAVORNPINYO W., HASTINGS I.M., WHITE N.J., MILLS A.J.
American Journal of Tropical Medicine and Hygiene , 2004
138.
The Use of Antimalarial Drugs against Viral Infection
D’Alessandro S., Scaccabarozzi D., Signorini L., Perego F., Ilboudo D.P., Ferrante P., Delbue S.
Microorganisms , 2020
139.
Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses
Efferth T., Marschall M., Wang X., Huong S., Hauber I., Olbrich A., Kronschnabl M., Stamminger T., Huang E.
Journal of Molecular Medicine , 2001
140.
The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication
Oiknine-Djian E., Weisblum Y., Panet A., Wong H.N., Haynes R.K., Wolf D.G.
Antimicrobial Agents and Chemotherapy , 2018
141.
Artemisone demonstrates synergistic antiviral activity in combination with approved and experimental drugs active against human cytomegalovirus.
Oiknine-Djian E., Bar-On S., Laskov I., Lantsberg D., Haynes R.K., Panet A., Wolf D.G.
Antiviral Research , 2019
142.
rcr_90_4_488bib142
Wang
Antiviral Res. , 2020
143.
Artemisinin Analogues as Potent Inhibitors of In Vitro Hepatitis C Virus Replication
Obeid S., Alen J., Nguyen V.H., Pham V.C., Meuleman P., Pannecouque C., Le T.N., Neyts J., Dehaen W., Paeshuyse J.
PLoS ONE , 2013
144.
Application of the Triazolization Reaction to Afford Dihydroartemisinin Derivatives with Anti-HIV Activity
Jana S., Iram S., Thomas J., Hayat M., Pannecouque C., Dehaen W.
Molecules , 2017
145.
Highly potent artemisinin-derived dimers and trimers: Synthesis and evaluation of their antimalarial, antileukemia and antiviral activities.
Reiter C., Fröhlich T., Gruber L., Hutterer C., Marschall M., Voigtländer C., Friedrich O., Kappes B., Efferth T., Tsogoeva S.B.
Bioorganic and Medicinal Chemistry , 2015
146.
Synthesis of Novel Hybrids of Quinazoline and Artemisinin with High Activities against Plasmodium falciparum, Human Cytomegalovirus, and Leukemia Cells
Fröhlich T., Reiter C., Ibrahim M.M., Beutel J., Hutterer C., Zeitträger I., Bahsi H., Leidenberger M., Friedrich O., Kappes B., Efferth T., Marschall M., Tsogoeva S.B.
ACS Omega , 2017
147.
rcr_90_4_488bib147
Capci
Chem. – Eur. J. , 2020
148.
Rezeng C., Yuan D., Long J., Suonan D., Yang F., Li W., Tong L., Jiumei P.
BioScience Trends , 2015
149.
Synthesis and anti-viral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon system.
Hwang D., Wu Y., Chang C., Lien T., Chen W., Tan U., Hsu J.T., Hsieh H.
Bioorganic and Medicinal Chemistry , 2006
150.
Parthenolide Influences Herpes simplex virus 1 Replication in vitro
Benassi-Zanqueta É., Marques C., Nocchi S., Dias Filho B., Nakamura C., Ueda-Nakamura T.
Intervirology , 2018
152.
Unusual nor-sesquiterpene lactone from the fruits of Illicium henryi
Liu J., Wang Y., Bi Y., Li H., Jia L., Bi Y., Zhang Y.
Tetrahedron Letters , 2013
153.
Sesquiterpene coumarins
Gliszczyńska A., Brodelius P.E.
Phytochemistry Reviews , 2011
154.
Influenza A (H1N1) Antiviral and Cytotoxic Agents from Ferula assa-foetida
Lee C., Chiang L., Cheng L., Liaw C., Abd El-Razek M.H., Chang F., Wu Y.
Journal of Natural Products , 2009
155.
Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-?B-inhibiting activity
Mazur I., Wurzer W.J., Ehrhardt C., Pleschka S., Puthavathana P., Silberzahn T., Wolff T., Planz O., Ludwig S.
Cellular Microbiology , 2007
156.
Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice
Ölschläger V., Pleschka S., Fischer T., Rziha H., Wurzer W., Stitz L., Rapp U.R., Ludwig S., Planz O.
Oncogene , 2004
157.
Methods to determine mechanism of action of anti-influenza inhibitors.
Luttick A., Hamilton S., Tucker S.P.
Methods in Molecular Biology , 2013
158.
A time-of–drug addition approach to target identification of antiviral compounds
Daelemans D., Pauwels R., De Clercq E., Pannecouque C.
Nature Protocols , 2011
159.
Current status on the development of pseudoviruses for enveloped viruses
Li Q., Liu Q., Huang W., Li X., Wang Y.
Reviews in Medical Virology , 2017
160.
Ebola Virus Entry: From Molecular Characterization to Drug Discovery
Salata C., Calistri A., Alvisi G., Celestino M., Parolin C., Palù G.
Viruses , 2019
161.
Two-electrode voltage clamp.
Guan B., Chen X., Zhang H.
Methods in Molecular Biology , 2013
162.
Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity
Zarubaev V.V., Pushkina E.A., Borisevich S.S., Galochkina A.V., Garshinina A.V., Shtro A.A., Egorova A.A., Sokolova A.S., Khursan S.L., Yarovaya O.I., Salakhutdinov N.F.
Virology , 2018
163.
Immunologic Mechanism of Patchouli Alcohol Anti-H1N1 Influenza Virus May Through Regulation of the RLH Signal Pathway In Vitro
Wu X., Ju D., Chen J., Yu B., Liu K., He J., Dai C., Wu S., Chang Z., Wang Y., Chen X.
Current Microbiology , 2013